Skip to main content

Advertisement

Call for Papers: The Two Sides of Hemp

The Editors of Journal of Cannabis Research are pleased to launch a call for papers for our new thematic series entitled, "The Two Sides of Hemp: Medical and Industrial".

We are especially interested in those papers that address developing medical and commercial uses of hemp and hemp products (such as cannabidiol) or those addressing differences between hemp and psychoactive cannabis.

For more information on the series and details on how to submit, you can read the call for papers here.

Most accessed articles RSS

View all articles

Aims and scope

Journal of Cannabis Research is an open access, peer-reviewed, international journal which welcomes submissions covering all topics pertaining to cannabis. 

The journal is an official publication of the Institute of Cannabis Research at Colorado State University-Pueblo.

Truly multidisciplinary

Our journal welcomes all aspects of cannabis research, divided into the following sections:

  • Agriculture and plant biology
  • Commerce, business, and environment
  • Endocannabinoid system
  • Cannabis and cannabinoids biochemistry and genetics
  • Cannabis and cannabinoids preclinical pharmacology
  • Cannabis and cannabinoids clinical pharmacology
  • Epidemiology and public health
  • Cannabis-related disorders
  • Medical cannabis
  • History, regulation, and public policy
Read about our sections

About the Institute

Journal of Cannabis Research is published in partnership with Colorado State University - Pueblo's Institute of Cannabis Research.

Visit the website

About the Editor-in-Chief

David GorelickDavid A. Gorelick, MD, PhD, DLFAPA, is Professor of Psychiatry (part-time) at the University of Maryland School of Medicine, having retired in October 2013 from the Intramural Research Program of the National Institute on Drug Abuse (NIDA), US National Institutes of Health (NIH) in Baltimore, Maryland.  

Dr Gorelick's research interests are the clinical pharmacology of substance use, substance withdrawal, and biological treatments of substance use disorders. His recent work focuses on cannabis (including its potential therapeutic uses), cocaine, and individuals with co-morbid psychiatric disorders.
 

Read more

Advertisement

Affiliated with

Advertisement